Following the footsteps of other pharma giants, Boehringer Ingelheim has embraced biosimilars, and established its own unit to develop and commercialize them. This timely development aligns Boehringer Ingelheim with U.S. Food and Drug Administration (FDA)'s...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)